🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Starling Oncology, Inc. (STLN)
NASDAQ: STLN · Real-Time Price · USD
3.000
-0.180 (-5.66%)
At close: Nov 20, 2026, 4:00 PM EST
2.990
-0.010 (-0.33%)
After-hours: Nov 20, 2026, 7:30 PM EST

Starling Oncology Revenue

Starling Oncology had revenue of $169.77M in the quarter ending September 30, 2026, with 24.31% growth. This brings the company's total for the last twelve months to $620.45M, up 34.58% year-over-year. In the year 2025, Starling Oncology had annual revenue of $502.73M with 27.79% growth. That makes Starling Oncology the 10,063rd largest company in the world by revenue and 2,161st in the United States.

Revenue (ttm)
$620.45M
Revenue Growth
+34.58%
P/S Ratio
0.49
Revenue / Employee
$967,936
Employees
641
Market Cap
305.97M

Revenue Chart

Revenue by Segment

  • Specialty Pharmacy 269.18M 53.5%
  • Patient Services 228.99M 45.5%
  • Clinical Trials & Other 4.56M 0.9%
Fiscal year ended Dec 31, 2025 See the full Starling Oncology breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025502.73M109.32M27.79%
Dec 31, 2024393.41M69.17M21.33%
Dec 31, 2023324.24M71.76M28.42%
Dec 31, 2022252.48M49.48M24.37%
Dec 31, 2021203.00M15.49M8.26%
Dec 31, 2020187.52M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.